microRNA Isolation, Expression Profiling, and Target Identification for Neuroprotection in Alzheimer’s Disease
Author:
Iqbal Saleem,Pal Debnath
Reference20 articles.
1. Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR (2015) Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS One 10:e0139233. https://doi.org/10.1371/journal.pone.0139233
2. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13:358–369. https://doi.org/10.1038/nrg3198
3. Iqbal S, Malik MZ, Pal D (2021) Network-based identification of miRNAs and transcription factors and in silico drug screening targeting delta-secretase involved in Alzheimer’s disease. Heliyon 7:e08502. https://doi.org/10.1016/j.heliyon.2021.e08502
4. Lin SY, Johnson SM, Abraham M, Vella MC, Pasquinelli A, Gamberi C, Gottlieb E, Slack FJ (2003) The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev Cell 4:639–650. https://doi.org/10.1016/s1534-5807(03)00124-2
5. Doench JG, Sharp PA (2004) Specificity of microRNA target selection in translational repression. Genes Dev 18:504–511. https://doi.org/10.1101/gad.1184404